Hester Biosciences last traded at ₹2,081.00 (2026-10-13). Over the past month the stock moved -8.7%, three months the stock moved +4.0%, year the stock moved +3.6%. Its closing range over 52 weeks is ₹1,318.95 – ₹2,438.10, with the latest close 14.6% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1987, Hester Biosciences Ltd is one of India’s leading animal healthcare companies and a major manufacturer of poultry and animal vaccines, including a leading position in PPR and Goat Pox vaccines.[1]
Business Overview[1] Hester operates an integrated animal healthcare platform across Poultry Healthcare and Animal Healthcare, offering vaccines, therapeutics, feed supplements, diagnostics, and petcare products. It's portfolio serves poultry farmers, livestock producers, veterinarians, and pet owners through a combination of R&D, manufacturing, quality systems, technical services, and field support.
In the latest quarter (Jun 2026), Hester Biosciences reported sales of ₹77.00 crore (-8.3%) and net profit of ₹97.00 crore (+470.6%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 77.00 | 23.00 | 29.00 | 97.00 | 114.00 |
| Mar 2026 | 100.00 | 34.00 | 34.00 | 17.00 | 18.78 |
| Dec 2025 | 77.00 | 18.00 | 23.00 | 9.00 | 10.31 |
| Sep 2025 | 71.00 | 12.00 | 17.00 | 14.00 | 16.99 |
| Jun 2025 | 84.00 | 23.00 | 27.00 | 17.00 | 19.33 |
| Mar 2025 | 82.00 | 19.00 | 23.00 | 2.00 | 1.52 |
| Dec 2024 | 63.00 | 5.00 | 8.00 | 11.00 | 13.71 |
| Sep 2024 | 84.00 | 19.00 | 23.00 | 8.00 | 9.64 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +20.0% | -6.0% | +3.8% | +2.4% | -15.5% | +22.2% | +22.0% | -8.3% |
| Operating profit growth | +46.2% | -50.0% | +18.8% | +27.8% | -36.8% | +260.0% | +78.9% | +0.0% |
| Net profit growth | +100.0% | +175.0% | -66.7% | +142.9% | +75.0% | -18.2% | +750.0% | +470.6% |
| EPS growth | +100.4% | +192.9% | -73.9% | +159.5% | +76.2% | -24.8% | +1135.5% | +489.8% |
| OPM % | 23.0% | 8.0% | 23.0% | 27.0% | 17.0% | 23.0% | 34.0% | 29.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Hester Biosciences reported sales of ₹333.00 crore (+7.1%) and net profit of ₹57.00 crore (+96.6%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 333.00 | 87.00 | 26.00 | 57.00 | 65.41 |
| Mar 2025 | 311.00 | 62.00 | 20.00 | 29.00 | 32.31 |
| Mar 2024 | 305.00 | 54.00 | 18.00 | 21.00 | 22.21 |
| Mar 2023 | 266.00 | 51.00 | 19.00 | 28.00 | 31.30 |
| Mar 2022 | 235.00 | 60.00 | 26.00 | 39.00 | 46.22 |
| Mar 2021 | 214.00 | 69.00 | 32.00 | 35.00 | 40.47 |
| Mar 2020 | 183.00 | 55.00 | 30.00 | 31.00 | 34.29 |
| Mar 2019 | 178.00 | 68.00 | 38.00 | 41.00 | 48.87 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +30.9% | +2.8% | +16.9% | +9.8% | +13.2% | +14.7% | +2.0% | +7.1% |
| Operating profit growth | +44.7% | -19.1% | +25.5% | -13.0% | -15.0% | +5.9% | +14.8% | +40.3% |
| Net profit growth | +78.3% | -24.4% | +12.9% | +11.4% | -28.2% | -25.0% | +38.1% | +96.6% |
| EPS growth | +62.3% | -29.8% | +18.0% | +14.2% | -32.3% | -29.0% | +45.5% | +102.4% |
| OPM % | 38.0% | 30.0% | 32.0% | 26.0% | 19.0% | 18.0% | 20.0% | 26.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Hester Biosciences.
Get Free AI Stock Analysis FREE →No recent news available for Hester Biosciences.
Hester Biosciences shares were last quoted at ₹2,081.00 (+1.1% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Hester Biosciences has a price-to-earnings (P/E) ratio of 13.63 and a price-to-book (P/B) ratio of 4.08. The industry P/E is 53.45.
The 52-week high of Hester Biosciences is ₹2,669.00 and the 52-week low is ₹1,250.95.
The market capitalisation of Hester Biosciences is about ₹1,856.28 crore.
In the latest quarter (Jun 2026), Hester Biosciences reported sales of ₹77.00 crore (-8.3%) and net profit of ₹97.00 crore (+470.6%), compared with the same quarter last year.
Promoters hold about 53.73% of Hester Biosciences.
Hester Biosciences belongs to the Pharmaceuticals & Drugs sector.